Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
Press releases published on May 17, 2025

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
Data confirmed TX45’s tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”) In new echocardiographic …

Brain Cancer Canada Awards $68,000 Research Grant for Clinical Trial of Anti-Cancer Vaccine Targeting DIPG, the Most Aggressive Pediatric Brain Cancer
TORONTO, May 17, 2025 (GLOBE NEWSWIRE) -- Today, on DIPG Awareness Day, Brain Cancer Canada is pleased to award $68,000 for an innovative research initiative led by Dr. Aru Narendran, MD, PhD, and Dr. Patrick Sipila, PhD, at The University of Calgary and …

Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
Data suggests that single dose of RJVA-001 leads to durable metabolic improvements with low systemic GLP-1 exposure in db/db mouse model of T2D— potentially simultaneously addressing durability, adherence, and tolerability challenges seen with current GLP- …

Tessera Therapeutics Features New Preclinical Data Demonstrating Progress Across its In Vivo Gene Writing™ Programs and Delivery Platform at the American Society of Gene and Cell Therapy 28th Annual Meeting
Presented new preclinical data in non-human primates (NHP) for alpha-1 antitrypsin deficiency (AATD) and phenylketonuria (PKU), where RNA Gene Writer achieved an estimated 76% and 70% editing in hepatocytes1, respectively New AATD data reinforced the …

Kailo Under Review: Best Pain Patch on the Market? Where to Buy Flex Pain Relief Patches
Sandy, May 17, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why chronic pain continues to affect millions despite modern medicine What makes traditional pain relief patches ineffective for long-term support How the Kailo Flex Pain Patch works …

Back to Life Complete Healthy Back System Under Review - Fix Back Pain Naturally
Beaverton, May 16, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: A comprehensive review of the Back to Life Complete Healthy Back System by Emily Lark, a natural approach to back wellness rooted in mobility and postural realignment. The true …

The Bone Density Solution Under Review: Blue Heron Health Osteoporosis Bone Health Guide by Shelly Manning
New York, May 16, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why osteoporosis and bone density loss are growing global concerns The overlooked symptoms and emotional burden of fragile bones How Shelly Manning’s Bone Density Solution offers …

Neuropathy No More Under Review: Blue Heron Health News' Nerve Pain Relief Tips Guide
Beaverton, May 16, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: What peripheral neuropathy is, why it occurs, and how it affects daily life Why conventional treatments for nerve pain relief often fall short or come with side effects How …